We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Reasons to Retain Equifax (EFX) Stock in Your Portfolio
Read MoreHide Full Article
Equifax Inc. (EFX - Free Report) remains focused on the expansion of its customer base through cloud data and technology transformation.
The company has an impressive Growth Score of B. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth.
Equifax has an expected long-term (three to five years) earnings per share growth rate of 15.1%. The company’s 2022 and 2023 earnings are expected to improve 14.4% and 16.6%, respectively, year over year.
Equifax has had an impressive run on the bourses over the past year. The stock has gained 29.9% against 29.5% decline of the industry it belongs to.
The company’s ongoing cloud data and technology transformation is aimed at driving innovation and product development, strengthening customer and partner integration. As part of the transformation, Equifax is migrating to a public cloud environment that engages virtual private cloud deployment techniques. The company remains focused on streamlining customers’ access to its analytical platforms.
Equifax remains focused on expanding and strengthening its customer base with efforts on delivering multi-data solutions by expanding differentiated data assets and analytics through organic growth, mergers and acquisitions, and partnerships. The company uses proprietary advanced analytical platforms, machine learning, artificial intelligence and advanced visualization tools.
The recent acquisition of Efficient Hire, which is now part of Equifax’s Workforce Solutions business unit, expands the company's portfolio of employer- and HR-focused solutions, boosting its ability to help clients manage their hiring and employment needs.
Some Risks
Equifax ’s has more long-term debt outstanding than cash. Cash and cash equivalent balance at the end of fourth-quarter 2021 was $224.7 million compared with the long-term debt level of $4.5 billion. Further, the cash level can't meet the short-term debt of $824.8 million.
Cross Country Healthcare has an expected long-term earnings per share (three to five years) growth rate of 6.6%. CCRN has a trailing four-quarter earnings surprise of 41.5%, on average.
FactSet has an expected earnings growth rate of around 15.1% for the current year. FDS has a trailing four-quarter earnings surprise of 6.1%, on average.
FactSet shares have surged 36.9% in the past year. FDS has a long-term earnings growth of 10%. FDS carries a Zacks Rank #2 (Buy).
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Reasons to Retain Equifax (EFX) Stock in Your Portfolio
Equifax Inc. (EFX - Free Report) remains focused on the expansion of its customer base through cloud data and technology transformation.
The company has an impressive Growth Score of B. This style score condenses all the essential metrics from a company’s financial statements to get a true sense of the quality and sustainability of its growth.
Equifax has an expected long-term (three to five years) earnings per share growth rate of 15.1%. The company’s 2022 and 2023 earnings are expected to improve 14.4% and 16.6%, respectively, year over year.
Equifax has had an impressive run on the bourses over the past year. The stock has gained 29.9% against 29.5% decline of the industry it belongs to.
Equifax, Inc. Price
Equifax, Inc. price | Equifax, Inc. Quote
Factors That Auger Well
The company’s ongoing cloud data and technology transformation is aimed at driving innovation and product development, strengthening customer and partner integration. As part of the transformation, Equifax is migrating to a public cloud environment that engages virtual private cloud deployment techniques. The company remains focused on streamlining customers’ access to its analytical platforms.
Equifax remains focused on expanding and strengthening its customer base with efforts on delivering multi-data solutions by expanding differentiated data assets and analytics through organic growth, mergers and acquisitions, and partnerships. The company uses proprietary advanced analytical platforms, machine learning, artificial intelligence and advanced visualization tools.
The recent acquisition of Efficient Hire, which is now part of Equifax’s Workforce Solutions business unit, expands the company's portfolio of employer- and HR-focused solutions, boosting its ability to help clients manage their hiring and employment needs.
Some Risks
Equifax ’s has more long-term debt outstanding than cash. Cash and cash equivalent balance at the end of fourth-quarter 2021 was $224.7 million compared with the long-term debt level of $4.5 billion. Further, the cash level can't meet the short-term debt of $824.8 million.
Zacks Rank and Stocks to Consider
Equifax currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the broader Zacks Business Services sector are FactSet Research Systems Inc. (FDS - Free Report) and Cross Country Healthcare, Inc. (CCRN - Free Report) .
Cross Country Healthcare has an expected long-term earnings per share (three to five years) growth rate of 6.6%. CCRN has a trailing four-quarter earnings surprise of 41.5%, on average.
Cross Country Healthcare’s shares have surged 76% in the past year. CCRN sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
FactSet has an expected earnings growth rate of around 15.1% for the current year. FDS has a trailing four-quarter earnings surprise of 6.1%, on average.
FactSet shares have surged 36.9% in the past year. FDS has a long-term earnings growth of 10%. FDS carries a Zacks Rank #2 (Buy).